An open-label, single-dose, parallel-group study of the pharmacokinetics and safety of HCV-796 in subjects with chronic hepatic impairment and in matched healthy adults
Phase of Trial: Phase I
Latest Information Update: 16 Apr 2008
At a glance
- Drugs Nesbuvir (Primary)
- Indications Hepatitis C
- Focus Pharmacokinetics
- 16 Apr 2008 Development of nesbuvir has been discontinued due to safety issues, according to a ViroPharma media release.
- 11 Apr 2008 Status changed from recruiting to completed.
- 11 Nov 2006 New trial record.